Published in Mayo Clin Proc on August 01, 1974
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Malignant lymphomas as tumours of the immune system. Br J Cancer (1980) 0.90
Morphological aspects of T cell subpopulations in human blood: characterization of the cerebriform mononuclear cells in healthy individuals. Clin Exp Immunol (1981) 0.88
Ultrastructural localization of acid phosphatase in rosetted T and B lymphocytes of normal human blood. Am J Pathol (1981) 0.83
Analysis of the peanut agglutinin-binding site as a differentiation marker of normal and malignant human lymphoid cells. Clin Exp Immunol (1981) 0.82
Mg2+-dependent adenosine triphosphatase as an enzyme histochemical marker for the lymphomas of B-cell origin. Am J Pathol (1979) 0.77
Absence of leukocyte-migration inhibitory factor in serum from patients with mycosis fungoides. Arch Dermatol Res (1976) 0.75
Cytochemical reactions of normal and neoplastic lymphocytes. J Clin Pathol (1977) 0.75
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med (1995) 2.89
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol (2000) 2.66
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. N Engl J Med (1973) 2.32
Identification by peroxidase staining of monocytes in surface immunofluorescence tests. J Immunol (1974) 2.29
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Antibody activity of human myeloma globulins. Semin Hematol (1973) 2.20
The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol (1994) 2.20
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest (1994) 1.99
Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood (1998) 1.87
The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci U S A (1989) 1.86
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia (2004) 1.81
The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res (1994) 1.72
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet (1975) 1.62
Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin Exp Immunol (1972) 1.57
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire. Br J Haematol (1998) 1.54
Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res (1999) 1.53
Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood (1975) 1.52
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol (1990) 1.48
A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J (1992) 1.46
BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol (1995) 1.42
B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant Rev (1973) 1.41
Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum (1993) 1.40
Low-grade MALT lymphoma mimicking Waldenström's macroglobulinemia. Leukemia (1999) 1.38
Bone densitometry in patients with multiple myeloma. Am J Med (1992) 1.38
A molecular defect in thrombasthenic platelets. J Clin Invest (1975) 1.36
Heavy chain diseases: current findings and concepts. Immunol Rev (1979) 1.35
Human monoclonal IgM with autoantibody activity against intermediate filaments. Proc Natl Acad Sci U S A (1982) 1.31
A new translocation in Burkitt's tumor cells. Hum Genet (1979) 1.30
The immunological classification of acute lymphoblastic leukemias. Cancer (1978) 1.29
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique. Leukemia (2008) 1.27
Association of the human type C retrovirus with a subset of adult T-cell cancers. Cancer Res (1983) 1.25
Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. EMBO J (1983) 1.22
Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol (1987) 1.20
IgD and IgM on the membrane of lymphoid cells in macroglobulinemia. Evidence for identity of membrane IgD and IgM antibody activity in a case with anti-IgG receptors. Eur J Immunol (1974) 1.20
Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood (1973) 1.19
Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients. Br J Haematol (1976) 1.19
A European de facto standard for image folders applied to telepathology and teaching. Int J Med Inform (1998) 1.18
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood (2000) 1.18
Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Français d'Hématologie Cellulaire. Br J Haematol (1999) 1.16
Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med (1980) 1.15
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer (1990) 1.15
Gelatinous transformation of the bone marrow: manifestation of an acute leukemia? Acta Haematol (1989) 1.12
Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood (1983) 1.11
Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer (1981) 1.11
Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology (1990) 1.10
Autoantibodies to nuclear lamin B in a patient with thrombopenia. Eur J Cell Biol (1987) 1.10
A variant form of hypergranular promyelocytic leukaemia (M3) Br J Haematol (1980) 1.09
Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis. Leuk Lymphoma (2006) 1.09
Acute lymphoblastic leukemia with pre-B-cell characteristics. Blood (1979) 1.09
Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant. J Natl Cancer Inst (1973) 1.08
Establishment of a human T-cell hybrid line with suppressive activity. Nature (1981) 1.08
Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry (1995) 1.08
Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Br J Cancer Suppl (1975) 1.06
Beta-glucuronidase activity in Sezary cells. Scand J Haematol (1974) 1.05
Fine structure of abmormal cells in hairy cell (tricholeukocytic) leukemia, with special reference to their in vitro phagocytic capacity. Lab Invest (1974) 1.05
Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol (1980) 1.05
Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Clin Exp Immunol (1976) 1.05
Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genet Cytogenet (1987) 1.02
Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases. Immunol Rev (1977) 1.02
Hairy cell leukaemia, occupation, and smoking. Br J Haematol (1995) 1.01
The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol (1985) 1.00
Interleukin 2-induced proliferation of leukemic human B cells. J Exp Med (1985) 1.00
Cytogenetic study of 75 erythroleukemias. Cancer Genet Cytogenet (2005) 0.99
Acquired immunodeficiency with intestinal cryptosporidiosis: possible transmission by Haitian whole blood. Lancet (1983) 0.98
[Angioimmunoblastic lymphadenopathies with autoimmune anemia and polyclonal hyperimmunoglobulinemia]. Nouv Presse Med (1976) 0.98
Phagocytosis of neutrophil polymorphonuclears by macrophages in human bone marrow: importance in granulopoiesis. J Clin Pathol (1980) 0.98
Human T lymphocyte receptors for IgM: reactivity with monomeric 8S subunit. J Immunol (1977) 0.98
Redistribution of intermediate filaments during capping of lymphocyte surface molecules. Nature (1982) 0.97
Membrane markers in "histiocytic" lymphomas (reticulum cell sarcomas). J Natl Cancer Inst (1976) 0.97
Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J Am Soc Nephrol (1999) 0.97
Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. Ann Intern Med (1988) 0.97
Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol (1999) 0.97
High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood (1993) 0.96